Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by nobody – 2019-04-05 06:37  – Posting: # 20124
Views: 1,288

» The fact that it is also a royal waste of money is of course only secondary.

Full-blown development mode. Accept it. Tell the sponsor you can't do the trial, if you are not qualified for PD-endpoint testing.

Kindest regards, nobody

Complete thread:

 Admin contact
20,262 posts in 4,265 threads, 1,401 registered users;
online 22 (0 registered, 22 guests [including 16 identified bots]).
Forum time (Europe/Vienna): 21:39 UTC

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz